UV1 cancer vaccine in pembrolizumab-treated patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma: results from the randomized phase 2 FOCUS trial

Anna Brandt; Konrad Klinghammer; Christoph Schultheiss; Lisa Paschold; Claudia Wickenhauser; Marcus Bauer; Anna Bergqvist; Dennis Hahn; Philippe Schafhausen; Mareike Tometten; Markus Blaurock; Henrike Barbara Zech; Chia-Jung Busch; Andreas Dietz; Urs Müller-Richter; Jürgen Alt; Andreas Boehm; Simone Kowoll; Jörg Steighardt; Alexander Lasch; Ingunn Hagen Westgaard; Marita Westhrin; Alexander Stein; Axel Hinke; Mascha Binder

doi:10.1101/2024.10.24.24315748

UV1 cancer vaccine in pembrolizumab-treated patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma: results from the randomized phase 2 FOCUS trial

Anna Brandt, Konrad Klinghammer, Christoph Schultheiss, Lisa Paschold, Claudia Wickenhauser, Marcus Bauer, Anna Bergqvist, Dennis Hahn, Philippe Schafhausen, Mareike Tometten, Markus Blaurock, Henrike Barbara Zech, Chia-Jung Busch, Andreas Dietz, Urs Müller-Richter, Jürgen Alt, Andreas Boehm, Simone Kowoll, Jörg Steighardt, Alexander Lasch, Ingunn Hagen Westgaard, Marita Westhrin, Alexander Stein, Axel Hinke, Mascha Binder

doi: https://doi.org/10.1101/2024.10.24.24315748

Anna Brandt

1Division of Medical Oncology, University Hospital Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Konrad Klinghammer

2Department of Hematology and Oncology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christoph Schultheiss

1Division of Medical Oncology, University Hospital Basel, Basel, Switzerland

3Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lisa Paschold

4Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Claudia Wickenhauser

5Institute of Pathology, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcus Bauer

5Institute of Pathology, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anna Bergqvist

6Ultimovacs ASA, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dennis Hahn

7Klinikum Stuttgart, Stuttgart, Germany; Dept. of Hematology, Oncology, Stem-Cell Transplantation and Palliative Care

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philippe Schafhausen

8Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mareike Tometten

9Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Markus Blaurock

10Department of Otorhinolaryngology, Head and Neck Surgery, University Medicine Greifswald, Greifswald, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Henrike Barbara Zech

11Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Chia-Jung Busch

10Department of Otorhinolaryngology, Head and Neck Surgery, University Medicine Greifswald, Greifswald, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andreas Dietz

12Department of Otolaryngology, Head and Neck Surgery, University of Leipzig, Leipzig, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Urs Müller-Richter

13University Hospital Würzburg, Bavarian Cancer Research Center (BZKF), Würzburg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jürgen Alt

14Department of Internal Medicine III (Hematology, Oncology), University Medical Center Mainz, Mainz, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andreas Boehm

15Department of Otorhinolaryngology, St. Georg Hospital, Leipzig, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Simone Kowoll

16Coordination Center for Clinical Trials, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jörg Steighardt

16Coordination Center for Clinical Trials, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alexander Lasch

16Coordination Center for Clinical Trials, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ingunn Hagen Westgaard

6Ultimovacs ASA, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marita Westhrin

6Ultimovacs ASA, Oslo, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alexander Stein

17Hematology-Oncology Practice Eppendorf (HOPE), Hamburg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Axel Hinke

18Clinical Cancer Research Consulting (CCRC), Düsseldorf, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mascha Binder

1Division of Medical Oncology, University Hospital Basel, Basel, Switzerland

3Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: mascha.binder@usb.de

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Article usage

Article usage: October 2024 to November 2024

	Abstract	Full	Pdf
Oct 2024	435	10	116
Nov 2024	161	6	288

View the discussion thread.

PreviousNext

Posted October 24, 2024.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following UV1 cancer vaccine in pembrolizumab-treated patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma: results from the randomized phase 2 FOCUS trial

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

UV1 cancer vaccine in pembrolizumab-treated patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma: results from the randomized phase 2 FOCUS trial

medRxiv 2024.10.24.24315748; doi: https://doi.org/10.1101/2024.10.24.24315748

Share This Article:

Citation Tools

UV1 cancer vaccine in pembrolizumab-treated patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma: results from the randomized phase 2 FOCUS trial

medRxiv 2024.10.24.24315748; doi: https://doi.org/10.1101/2024.10.24.24315748

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Oncology

Subject Areas

All Articles

Addiction Medicine (390)
Allergy and Immunology (705)
Anesthesia (195)
Cardiovascular Medicine (2874)
Dentistry and Oral Medicine (327)
Dermatology (244)
Emergency Medicine (432)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1015)
Epidemiology (12597)
Forensic Medicine (10)
Gastroenterology (809)
Genetic and Genomic Medicine (4470)
Geriatric Medicine (405)
Health Economics (717)
Health Informatics (2865)
Health Policy (1056)
Health Systems and Quality Improvement (1056)
Hematology (378)
HIV/AIDS (905)
Infectious Diseases (except HIV/AIDS) (14011)
Intensive Care and Critical Care Medicine (834)
Medical Education (418)
Medical Ethics (115)
Nephrology (465)
Neurology (4226)
Nursing (226)
Nutrition (619)
Obstetrics and Gynecology (791)
Occupational and Environmental Health (725)
Oncology (2216)
Ophthalmology (629)
Orthopedics (255)
Otolaryngology (321)
Pain Medicine (269)
Palliative Medicine (83)
Pathology (488)
Pediatrics (1181)
Pharmacology and Therapeutics (491)
Primary Care Research (485)
Psychiatry and Clinical Psychology (3677)
Public and Global Health (6810)
Radiology and Imaging (1499)
Rehabilitation Medicine and Physical Therapy (872)
Respiratory Medicine (904)
Rheumatology (430)
Sexual and Reproductive Health (433)
Sports Medicine (372)
Surgery (474)
Toxicology (59)
Transplantation (204)
Urology (175)